{
    "organizations": [],
    "uuid": "efd8c6f801f86a2351016bff7c1fd1e47292ff86",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-china-regenerative-medicine-inform/brief-china-regenerative-medicine-informed-that-all-favour-intends-to-dispose-2-bln-shares-of-co-idUSFWN1PK05A",
    "ord_in_thread": 0,
    "title": "BRIEF-China Regenerative Medicine Informed That All Favour Intends To Dispose 2 Bln Shares Of Co",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - China Regenerative Medicine International Ltd:\n* ANNOUNCES ACQUISITION OF SHARES BY LISTED COMPANY IN CHINA FROM A SUBSTANTIAL SHAREHOLDER OF COMPANY\n* DISPOSAL FOR ‚ÄçHK$360 MILLION * INFORMED THAT ALL FAVOUR HOLDINGS INTENDED TO DISPOSE OF 2 BILLION SHARES OF CO TO BLB INTERNATIONAL Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)\n ",
    "published": "2018-01-25T18:15:00.000+02:00",
    "crawled": "2018-01-26T21:15:02.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "china",
        "regenerative",
        "medicine",
        "international",
        "ltd",
        "announces",
        "acquisition",
        "share",
        "listed",
        "company",
        "china",
        "substantial",
        "shareholder",
        "company",
        "disposal",
        "million",
        "informed",
        "favour",
        "holding",
        "intended",
        "dispose",
        "billion",
        "share",
        "co",
        "blb",
        "international",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}